Clinical Trials Logo

Clinical Trial Summary

Randomized phase III trial to compare the effectiveness of methotrexate with that of dactinomycin in treating patients who have gestational trophoblastic neoplasia. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether methotrexate is more effective than dactinomycin in treating patients with gestational trophoblastic neoplasia.


Clinical Trial Description

OBJECTIVES:

I. Compare the efficacy of methotrexate vs dactinomycin, as measured by complete response rate, in patients with low-risk gestational trophoblastic neoplasia.

II. Compare the toxicity of these regimens in these patients. III. Determine whether the definition of persistent gestational trophoblastic neoplasia is accurate (as determined by the likelihood that the beta human chorionic gonadotropin [HCG] titer would decline on the day treatment is initiated).

OUTLINE: This is a randomized study. Patients are randomized to 1 of 2 treatment arms.

ARM I: Patients receive methotrexate intramuscularly once weekly in the absence of disease progression or unacceptable toxicity.

ARM II: Patients receive dactinomycin IV over 15 minutes every 2 weeks in the absence of disease progression or unacceptable toxicity. All patients continue on treatment until 1 beta human chorionic gonadotropin (HCG) titer is below the institutional normal. Patients then receive 1 additional consolidation treatment.

Patients are followed every 4 weeks for 1 year. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00003702
Study type Interventional
Source Gynecologic Oncology Group
Contact
Status Completed
Phase Phase 3
Start date June 1999

See also
  Status Clinical Trial Phase
Recruiting NCT02892877 - The French National Reference Centre of GTD N/A
Recruiting NCT01630954 - A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole Phase 4
Completed NCT01535053 - Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia Phase 3
Completed NCT00190918 - A Trial for Patients With Gestational Trophoblastic Disease Phase 2
Recruiting NCT03785574 - Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule N/A
Completed NCT01984099 - RCT on the Efficacy of Methotrexate for the Prevention of GTD Phase 3
Not yet recruiting NCT05637892 - A Cohort Study of Hydatidiform Mole